Non-Small Cell Lung Cancer Coverage from Every Angle

Clemens Grassberger, PhD, on NSCLC: Therapy Sequencing Criteria

Posted: Wednesday, October 4, 2017

Clemens Grassberger, PhD, of Harvard Medical School, discusses tumor-specific modeling of chemotherapy combined with radiation in stage III non–small cell lung cancer, which suggests novel patient stratification criteria for therapy sequencing.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.